Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTINA ECONOMOS

Allopathic & Osteopathic Physicians General Practice

NPI
1861634412
CMS profile
615552
Location
HONOLULU, HI

General Payments · PY2018–2024

$4,689.14

  • Reported across 151 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$629.88

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $629.88 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BOSTON SCIENTIFIC CORPORATION $171.02 1
Lilly USA, LLC $153.48 3
Acerta Pharma LLC $132.07 2
ABBVIE INC. $67.68 2
Bayer HealthCare Pharmaceuticals Inc. $43.60 2
Novo Nordisk AS $22.44 1
GlaxoSmithKline, LLC. $21.00 1
Amgen Inc. $18.59 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,171.93 25
PY2019 $522.76 14
PY2020 $176.61 9
PY2021 $1,007.95 51
PY2022 $742.53 23
PY2023 $437.48 16
PY2024 $629.88 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $34.04 02/22/2024 Food and Beverage Undisputed 01/23/2026 1103675313 CMS
ABBVIE INC. $33.64 06/13/2024 Food and Beverage Undisputed 01/23/2026 1103675315 CMS
Amgen Inc. $18.59 07/30/2024 Food and Beverage Undisputed 01/23/2026 1117244023 CMS
AstraZeneca Pharmaceuticals LP $10.08 03/14/2024 Food and Beverage Undisputed 01/23/2026 1104764936 CMS
AstraZeneca Pharmaceuticals LP $121.99 07/17/2024 Food and Beverage Undisputed 01/23/2026 1105535600 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.54 08/06/2024 Food and Beverage Undisputed 01/23/2026 1086241144 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.06 11/26/2024 Food and Beverage Undisputed 01/23/2026 1086125726 CMS
Boston Scientific Corporation $171.02 06/10/2024 Food and Beverage Undisputed 01/23/2026 1092742201 CMS
GlaxoSmithKline, LLC. $21.00 03/29/2024 Food and Beverage Undisputed 01/23/2026 1116436553 CMS
Lilly USA, LLC $124.40 01/17/2024 Food and Beverage Undisputed 01/23/2026 1136107683 CMS
Lilly USA, LLC $7.86 02/22/2024 Food and Beverage Undisputed 01/23/2026 1136107685 CMS
Lilly USA, LLC $21.22 07/23/2024 Food and Beverage Undisputed 01/23/2026 1136106821 CMS
Novo Nordisk Inc $22.44 05/28/2024 Food and Beverage Undisputed 01/23/2026 1096995664 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.